Organization
Jiangsu Renocell Biotech
3 clinical trials
Clinical trial
A Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of RY_SW01 Cell Injection Therapy in Systemic SclerosisStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of RY_SW01cell Injection Therapy in Active Lupus NephritisStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Phase I Clinical Study of in Vivo Distribution and Metabolic Kinetic Characterization of 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic SclerosisStatus: Not yet recruiting, Estimated PCD: 2025-05-31